SCHEMBL4732475

SCHEMBL4732475

Fc1ccc(-c2ccc(NC3CCN(c4ncccn4)CC3)c(F)c2)c(F)c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
PKM P14618 1/20 0.52
KDM4E B2RXH2 1/20 0.45
DPP4 P27487 1/20 0.43
DPP8 Q6V1X1 1/20 0.43
DPP9 Q86TI2 1/20 0.43
DPP7 Q9UHL4 1/20 0.43
JAK1 P23458 1/20 0.42
SCD O00767 1/20 0.40
SLC6A7 Q99884 1/20 0.40
MAPK1 P28482 1/20 0.39
DRD2 P14416 2/20 0.39
DRD4 P21917 2/20 0.39
DRD3 P35462 2/20 0.39
TP53 P04637 1/20 0.39
OPRM1 P35372 1/20 0.38
DYRK1A Q13627 1/20 0.38
FAAH O00519 1/20 0.38
GRM2 Q14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4732472 0.90 ALDH1A1 (0.47) ALDH1A1PKMKDM4EDPP4DPP8
SCHEMBL4731711 0.90 ALDH1A1 (0.47) ALDH1A1PKMKDM4EDPP4DPP8
SCHEMBL4729603 0.89 SCD (0.51) ALDH1A1PKMKDM4EDPP4DPP8
SCHEMBL4730640 0.88 ALDH1A1 (0.44) ALDH1A1PKMKDM4EDPP4DPP8
SCHEMBL4731167 0.86 KDM4E (0.46) ALDH1A1PKMKDM4EDPP4DPP8
SCHEMBL5090496 0.83 MALT1 (0.45) ALDH1A1PKMKDM4ESCDSLC6A7
SCHEMBL4731925 0.82 CNR1 (0.49) ALDH1A1PKMKDM4ESCDSLC6A7
SCHEMBL4733745 0.81 KDM4E (0.48) ALDH1A1PKMKDM4EDPP4DPP8
SCHEMBL4732131 0.81 ALDH1A1 (0.46) ALDH1A1PKMKDM4EDPP4DPP8
SCHEMBL5102741 0.80 SLC6A7 (0.51) ALDH1A1PKMKDM4ESLC6A7TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139598-A1 Amine-linked Multicyclic Compounds and Methods of Their Use LEXICON PHARMACEUTICALS, INC. 2008-06-12 US claimed
WO-2008058064-A1 AMINE-LINKED MULTICYCLIC COMPOUNDS AS INHIBITORS OF THE PROLINE TRANSPORTER LEXICON PHARMACEUTICALS, INC. (US) 2008-05-15 WO claimed
US-20080139598-A1 Amine-linked Multicyclic Compounds and Methods of Their Use LEXICON PHARMACEUTICALS, INC. 2008-06-12 US disclosed
WO-2008058064-A1 AMINE-LINKED MULTICYCLIC COMPOUNDS AS INHIBITORS OF THE PROLINE TRANSPORTER LEXICON PHARMACEUTICALS, INC. (US) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139598-A1 Amine-linked Multicyclic Compounds and Methods of Their Use MAOB, HNMT, MAOA ALDH1A1 287/4885PKM 1033/4885KDM4E 2225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.